ID
16329
Beschrijving
Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With Anastrozole; ODM derived from: https://clinicaltrials.gov/show/NCT00623519
Link
https://clinicaltrials.gov/show/NCT00623519
Trefwoorden
Versies (1)
- 11-07-16 11-07-16 -
Geüploaded op
11 juli 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT00623519
Eligibility Breast Cancer NCT00623519
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
metastatic disease
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1282506
- UMLS CUI [1,2]
- C0027627
Beschrijving
patients unsuitable to receive the medication according the anastrozole label
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0290883
- UMLS CUI [1,2]
- C3839996
Beschrijving
informed consent
Datatype
boolean
Alias
- UMLS CUI [1]
- C0021430
Similar models
Eligibility Breast Cancer NCT00623519
- StudyEvent: Eligibility
C0678222 (UMLS CUI [1,2])
C1514888 (UMLS CUI [1,3])
C0279025 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2])
C0949878 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,2])
C3839996 (UMLS CUI [1,2])